ERBB2 and breast cancer: Among the different types of breast cancer, the most aggressive and with the poorer prognosis is the triple-negative one, characterized by the absence of estrogen and progesterone receptors and by the lack of overexpression for human epidermal growth factor receptor 2 (HER2) protein.